US Broker Ratings

argenx SE (ARGX) Stock Analysis: A Biotech Powerhouse with 37% Upside Potential

argenx SE (ARGX), a prominent player in the biotechnology sector based in the Netherlands, has been capturing investor attention with its impressive growth trajectory and promising future potential. With a..

Mettler-Toledo International, Inc. (MTD) Stock Analysis: Navigating a 2.41% Potential Upside Amidst Market Challenges

Mettler-Toledo International, Inc. (NYSE: MTD), a formidable player in the healthcare sector’s diagnostics and research industry, stands as a key provider of precision instruments worldwide. Operating across the Americas, Europe,..

Haleon plc (HLN) Stock Analysis: Exploring a 16% Potential Upside in the Healthcare Sector

Haleon plc (HLN), a significant player in the healthcare sector, has been capturing investor attention with its robust portfolio of consumer healthcare products and a promising potential upside of 16.04%...

Waters Corporation (WAT) Stock Analysis: 10.17% Potential Upside Amid Strong Analyst Confidence

Waters Corporation (NYSE: WAT), a global leader in diagnostic and research solutions within the healthcare sector, presents a compelling opportunity for investors in search of steady growth and innovation in..

Danaher Corporation (DHR) Stock Analysis: What 20.85% Potential Upside Means for Investors

Danaher Corporation (NYSE: DHR), a major player in the healthcare sector, is drawing significant attention from investors, thanks to its robust market position and promising growth potential. With a market..

Edwards Lifesciences Corporation (EW) Stock Analysis: Navigating Growth in the Medical Device Sector

Edwards Lifesciences Corporation (NYSE: EW) stands as a cornerstone in the healthcare sector, specifically within the medical devices industry. Headquartered in Irvine, California, Edwards Lifesciences is renowned for its innovative..

Zoetis Inc. (ZTS) Stock Analysis: Uncovering a 25.86% Potential Upside in the Animal Health Leader

Zoetis Inc. (NYSE: ZTS), a leader in the animal health industry, is catching the eye of investors with a compelling potential upside of 25.86%. With a market capitalization of $68.99..

Humana Inc. (HUM) Stock Analysis: Navigating a 28% Potential Upside Amid Healthcare Sector Dynamics

As investors seek opportunities in the ever-evolving healthcare sector, Humana Inc. (NYSE: HUM) presents a compelling case with a potential upside of 28.33%. With a market capitalization of $27.84 billion,..

Sanofi (SNY) Stock Analysis: Why This Healthcare Giant Offers a Compelling 31.40% Upside

Sanofi (SNY), a leading player in the global healthcare industry, presents a compelling investment opportunity for those looking to capitalize on its promising growth prospects. With a market capitalization of..

IQVIA Holdings, Inc. (IQV): Investor Outlook Reveals Strong Buy Ratings and a 16.5% Upside Potential

IQVIA Holdings, Inc. (NYSE: IQV), a leader in the healthcare diagnostics and research sector, is capturing attention with its robust market presence and forward-looking growth potential. With a market capitalization..

Alcon Inc. (ALC) Stock Analysis: Exploring a 20.93% Potential Upside for Investors

Alcon Inc. (ALC), a stalwart in the healthcare sector, operates at the forefront of the medical instruments and supplies industry. Headquartered in Geneva, Switzerland, Alcon specializes in eye care products,..

IDEXX Laboratories, Inc. (IDXX) Investor Outlook: Strong Revenue Growth Amidst Market Volatility

IDEXX Laboratories, Inc. (NASDAQ: IDXX), a leading player in the healthcare sector specializing in diagnostics and research, is making headlines with its robust market presence and innovative approach in veterinary..

Takeda Pharmaceutical Company L (TAK) Stock Analysis: Unveiling a 14.65% Potential Upside for Investors

Takeda Pharmaceutical Company Limited (NYSE: TAK), a stalwart in the healthcare sector and a titan among drug manufacturers, is drawing attention from investors with its impressive 14.65% potential upside. Headquartered..

Veeva Systems Inc. (VEEV) Investor Outlook: Navigating Growth in the Health Information Services Sector

Veeva Systems Inc. (NYSE: VEEV), a dominant force in the healthcare information services sector, is capturing investor attention with its robust market cap of $45.08 billion. As a cloud-based software..

The Cigna Group (CI) Investor Outlook: Analyzing a Potential 23.76% Upside in the Healthcare Sector

For investors eyeing the healthcare sector, The Cigna Group (NYSE: CI) presents a compelling opportunity with an impressive potential upside of 23.76% based on current analyst targets. As one of..

Stryker Corporation (SYK) Stock Analysis: Navigating Growth with an 8.22% Potential Upside

Stryker Corporation (NYSE: SYK), a formidable player in the healthcare sector, is making waves in the medical devices industry with its robust market presence and innovative technology solutions. With a..

Novo Nordisk A/S (NVO) Investor Outlook: Potential 26% Upside Amid Robust Revenue Growth

Novo Nordisk A/S (NVO), a titan in the healthcare sector, stands out with its impressive market capitalization of $305.86 billion. As a global leader in the pharmaceutical industry, particularly in..

Bristol-Myers Squibb (BMY) Stock Analysis: Evaluating a 21.84% Potential Upside

Bristol-Myers Squibb Company (NYSE: BMY), a titan in the healthcare sector and a key player in the drug manufacturers’ industry, commands a significant market presence with a market capitalization of..

Becton, Dickinson and Company (BDX): Investor Outlook Reveals 23.79% Potential Upside

Becton, Dickinson and Company (NYSE: BDX), a stalwart in the healthcare sector, presents an intriguing investment proposition, particularly for those eyeing the medical instruments and supplies industry. With a market..

HCA Healthcare, Inc. (HCA) Stock Analysis: A Strong ROE Amidst Moderate Upside Potential

HCA Healthcare, Inc. (HCA), a prominent player in the United States healthcare sector, stands out with its commanding market presence and robust financial metrics. As of today, HCA’s market capitalization..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds